Safety and Persistence of Nalmefene Treatment for Alcohol Dependence. Results from Two Post-authorisation Safety Studies
Author(s) -
Jonathan Chick,
Frank Andersohn,
S. Guillo,
Kathrin Borchert,
Massoud Toussi,
Sebastian Braun,
Jennifer Scarlet Haas,
Kavitha Kuppan,
Ole Lemming,
Elin Heldbo Reines,
Florence Tubach
Publication year - 2021
Publication title -
alcohol and alcoholism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.747
H-Index - 99
eISSN - 1464-3502
pISSN - 0735-0414
DOI - 10.1093/alcalc/agab045
Subject(s) - nalmefene , medicine , discontinuation , tolerability , retrospective cohort study , nausea , adverse effect , cohort , population , cohort study , pediatrics , emergency medicine , environmental health , naltrexone , receptor , opioid
Two post-authorisation studies assessed the safety and persistence of patients' use of nalmefene.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom